CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancerRaymond J. Lim, Bin Liu, Ramin Salehi‐Rad et al.|Cell Reports Medicine|2024Cited by 111
Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non–Small Cell Lung CancerRui Li, Steven M. Dubinett, Ramin Salehi‐Rad et al.|Cancer Research|2021Cited by 98
CCL21-DC in situ vaccination in murine NSCLC overcomes resistance to immunotherapy and generates systemic tumor-specific immunityRamin Salehi‐Rad, Steven M. Dubinett, Tian-hao Zhang et al.|Journal for ImmunoTherapy of Cancer|2023Cited by 30
Novel Kras-mutant murine models of non-small cell lung cancer possessing co-occurring oncogenic mutations and increased tumor mutational burdenRamin Salehi‐Rad, Steven M. Dubinett, Rui Li et al.|Cancer Immunology Immunotherapy|2021Cited by 24
Single-Cell Characterization of Pulmonary Nodules Implicates Suppression of Immunosurveillance across Early Stages of Lung AdenocarcinomaJane Yanagawa, Steven M. Dubinett, Linh M. Tran et al.|Cancer Research|2023Cited by 19